Vimarsana
Biggest News Aggregation in the World

Page 8 - Tender Offer Statement News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Tender Offer Statement. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Tender Offer Statement Today - Breaking & Trending Today

Euronav : to acquire CMB.TECH as part of its new strategy -December 22, 2023 at 04:32 pm EST - Vimarsana News

Euronav : to acquire CMB.TECH as part of its new strategy -December 22, 2023 at 04:32 pm EST

Euronav to acquire CMB.TECH as part of its new strategy 22 Dec 2023 22:01 CET Subscribe ...

Renesas Extends Tender Offer for Proposed Acquisition of Sequans - Vimarsana News

Renesas Extends Tender Offer for Proposed Acquisition of Sequans

Renesas Electronics Corporation and Sequans Communications S.A. today announced that Renesas has extended the expiration date of its tender offer to acquire all of the outstanding ordinary shares...

GDEV : announces commencement of self tender offer to purchase for cash... -December 19, 2023 at 06:04 am EST - Vimarsana News

GDEV : announces commencement of self tender offer to purchase for cash... -December 19, 2023 at 06:04 am EST

GDEV announces commencement of self tender offer to purchase for cash a minimum of 15,000,000, up to 20,000,000 of its ordinary shares at a purchase price of $2.00 per ordinary share ...

Renesas Extends Tender Offer for Proposed Acquisition of Sequans - Vimarsana News

Renesas Extends Tender Offer for Proposed Acquisition of Sequans

<h4><i>Shareholders to Receive U.S. $0.7575 per Ordinary Share and U.S. $3.03 per ADS in cash</i></h4><p/>Tokyo, Japan and Paris, France - <a href="https://www.newsfilecorp.com/">Newsfile Corp.</a> - February 20, 2024 - Renesas Electronics Corporation (TSE: 6723) ("Renesas") and Sequans Communications S.A.

AstraZeneca to Acquire Icosavax, Including Potential First-in-class RSV and hMPV Combination Vaccine With Positive Phase II Data - Vimarsana News

AstraZeneca to Acquire Icosavax, Including Potential First-in-class RSV and hMPV Combination Vaccine With Positive Phase II Data

Building on expertise in RSV prevention, acquisition will accelerate ambition to deliver portfolio of protective interventions to address high unmet needs in infectious diseases ...